ANGO
$17.04
Angiodynamics
$.01
.06%
ANGO
Earnings Whisper ®
N/A
2nd Quarter November 2017
Consensus:  $0.17
Revenue:  $88.61 Mil
Friday
Jan 5
6:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, September 28, 2017

What do you expect when ANGO reports earnings?
Beat
Meet
Miss

Where is ANGO's stock price going from here?
Up
Flat
Down
Stock chart of ANGO
Analysts
Summary of analysts' recommendations for ANGO
Score
Grade
Pivots
Resistance
$17.33
$17.24
$17.13

$17.04

Support
$16.93
$16.84
$16.73
Tweet
Growth
Description
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The Company's diverse product line includes angiographic products and accessories, dialysis products, vascular access products, PTA products, drainage products, thrombolytic products and venous products.
Peers
Abbott LaboratoriesBoston ScientificStrykerBecton, DickinsonC. R. BardBaxter InternationalWatersIntegra LifeSciences Holdings3MResMed